Us Food And Drug Administration
Source:Economic Times - MUMBAI: Jubilant Life Sciences was witnessing selling pressure after one of its manufacturing facilities, Jubilant HollisterStier, located at Washington in the US, was issued a warning letter (WL) by US Food and Drug Administration.
3.28 PM Dec 5th
Jubilant Life Sciences Limited has informed the Exchange that one of its manufacturing facilities, Jubilant HollisterStier, LLC (JHS) located at Spokane, Washington State, US has been issued a Warning Letter (WL) by US Food and Drug Administration (FDA).
12.59 PM Dec 5th
Jubilant Life Sciences Ltd, a global pharmaceutical and life sciences company, has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (US FDA) for quetiapine fumarate tablet 25 mg (base), the generic version of AstraZeneca`s Seroquel, which
1.28 PM Dec 1st
Guys people saying that wockhartdt going to be next ranbaxy. please go through sequence of events below of ranbaxy and share your views on wockhardt future.. CHAIN OF EVENTS 2006: US Food and Drug Administration (FDA) inspectors note allegations about Ranbaxy`s practices 2007: Whistle
6.11 PM Nov 27th
Source:FirstPost - Mumbai: The US Food and Drug Administration has imposed an "import alert", effectively a ban, on the Chikalthana plant operated by Indian generic drugmaker Wockhardt Ltd, the regulator said in a notice on its website, sending the company`s shares down as much as 13
11.15 AM Nov 27th
Follow moneycontrol.comFacebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.